You are viewing the site in preview mode

Skip to main content


Fig. 1 | BMC Health Services Research

Fig. 1

From: Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis

Fig. 1

Study design and timeline diagram. The pre-index variables were evaluated from claims during the 6-month pre-index period. The index date was defined as the date of first prescription fill of lurasidone or quetiapine. The outcome variables were evaluated from claims in the 6-month follow-up (post-index) period. Treatment episodes began at, or after, the index date, and could have ended prior to the end of the 6-month follow-up period if the either of the following occurred: treatment discontinuation or a switch to another antipsychotic

Back to article page